Table 1.

Comparison of data between the training set and the validation set [mean ± SD/M (P₂₅, P₇₅)]

Patient characteristics	Training set (n=207)	Validation set (n=90)	t/Z	P
Age, year	51.34±8.09	52.39±8.09	1.025	0.306
BMI, kg/m2	23.74±2.57	23.67±2.97	0.222	0.825
CA125, U/mL	27.02 (15.71, 42.82)	28.18 (19.77, 44.18)	0.835	0.404
CA19-9, U/mL	20.84 (11.84, 32.32)	21.50 (13.01, 35.01)	0.948	0.343
HE4, pmol/L	70.20 (48.20, 96.10)	70.30 (52.50, 88.00)	0.209	0.835
VEGF, ng/L	291.68±95.87	291.56±102.00	0.009	0.993
D-dimer, ng/mL	351.40±143.79	336.00±133.19	0.864	0.388
RBC, 109/L	3.96±1.28	3.82±1.14	0.860	0.391
MCH, g/L	128.44±1.74	128.26±1.88	0.814	0.416
MCV, fL	87.40±1.32	87.22±1.27	1.115	0.266
RDW, fL	44.43±2.99	44.23±2.50	0.540	0.590
PLT, 109/L	223.97±63.02	230.28±72.78	0.753	0.452
MPV, fL	12.10 (10.80, 12.90)	11.75 (10.20, 12.90)	1.429	0.153
PDW, fL	13.96±2.09	13.55±2.19	1.525	0.128
WBC, 109/L	6.52±1.42	6.26±1.31	0.860	0.391
N, 109/L	3.76±1.27	3.77±1.27	1.462	0.145
L, 109/L	1.90 (1.52, 2.36)	1.96 (1.53, 2.27)	0.220	0.826
MON, 109/L	0.33±0.11	0.34±0.11	0.662	0.508
NLR	1.95 (1.47, 2.53)	1.94 (1.36, 2.52)	0.078	0.938
PLR	111.71 (88.02, 150.73)	114.43 (91.56, 159.46)	0.561	0.575
MLR	0.17 (0.12, 0.23)	0.17 (0.14, 0.22)	0.357	0.721

Note: BMI: body mass index; CA125: carbohydrate antigen 125; CA19-9: carbohydrate antigen 19-9; VEGF: vascular endothelial growth factor; HE4: human epididymis secretory protein 4; RBC: red blood cell count; MCH: mean corpuscular hemoglobin content; MCV: mean corpuscular volume; RDW: red blood cell distribution width; PLT: platelet count; MPV: mean platelet volume; PDW: platelet distribution width; WBC: white blood cell count; N: absolute neutrophil count; L: absolute lymphocyte count; MON: monocyte count; NLR: neutrophil to lymphocyte ratio; PLR: platelet to lymphocyte ratio; MLR: monocyte to lymphocyte ratio.